Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?

Aliment Pharmacol Ther. 2018 Mar;47(6):848-849. doi: 10.1111/apt.14508.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents*
  • Hepacivirus
  • Hepatitis C*
  • Hepatitis C, Chronic*
  • Humans
  • Interferons
  • Kinetics
  • Sofosbuvir
  • Sustained Virologic Response
  • Treatment Failure

Substances

  • Antiviral Agents
  • Interferons
  • Sofosbuvir